Immunome Inc

IMNMNASDAQ · USD
21.62USD-0.06 (-0.28%)
2210

Immunome Inc (IMNM) Covered Calls

As of September 28, 2026, IMNM has 43 covered call opportunities in the coming three months. Return ranges from 3.2 to 89.2% until expiration. Annualized return ranges from 19.7 to 701.4%. The nearest expiration is October 16, 2026. Maximum potential profit is $1,909.

Read more

Running IMNM covered calls helps you generate consistent income from Immunome Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Immunome Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best IMNM covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if IMNM stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling IMNM covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Immunome Inc covered call is worth writing.

Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product candidate for the treatment of SARS-CoV-2 infections and COVID-19. The company was incorporated in 2006 and is headquartered in Exton, Pennsylvania.

Income-focused investors, long-term IMNM holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling IMNM covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Immunome Inc covered calls come to you, already filtered for the metrics that matter.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile52.78% Neutral
  • Market cap (M$)2,462
  • 52 weeks high-27.88%
  • 52 weeks low95.49%
  • Analyst recommendationStrong Buy
    1.07
  • Target price$36.00
    67.95% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-05
  • P/E—
  • Future P/E—
  • EPS (ttm)-2.53
  • EPS growth next 5 years14.84%

As of September 28, 2026

2026-10-162130.0040.120.051.35864.0040.35701.41-0.23+0.20671.30
2026-10-162127.0026.110.054.90564.0026.34457.86-0.23+0.42884.85
2026-10-162125.0016.770.150.45374.0017.47303.62-0.70+0.183960.30
2026-12-188435.0063.480.051.801364.0063.71276.83-0.23+0.214071.75
2026-12-188430.0040.120.304.90889.0041.52180.43-1.40+0.395284.60
2027-01-1511230.0040.120.054.90864.0040.35131.51-0.23+0.393764.85
2026-11-205625.0016.770.552.65414.0019.34126.03-2.57+0.3902.10
2027-01-1511229.0035.450.104.90769.0035.92117.05-0.47+0.4004.80
2027-04-1620335.0063.480.104.901369.0063.94114.97-0.47+0.3604.80
2027-04-1620334.0058.800.104.901269.0059.27106.57-0.47+0.3604.80

As of September 28, 2026

Sell covered calls with the data behind you

Find the best IMNM covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.

Start your 14-day free trial